SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001387131-23-008497
Filing Date
2023-07-18
Accepted
2023-07-18 17:24:36
Documents
17
Period of Report
2023-06-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K tnxp_8ka-063023.htm   iXBRL 8-K/A 35445
2 CONSENT OF KPMG LLP ex23-01.htm EX-23.01 5307
3 AUDITED ABBREVIATED FINANCIAL STATEMENTS ex99-01.htm EX-99.01 120304
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION ex99-02.htm EX-99.02 175437
8 GRAPHIC ex23-01_img01.jpg GRAPHIC 9900
9 GRAPHIC ex9901001.jpg GRAPHIC 1601
  Complete submission text file 0001387131-23-008497.txt   555661

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tnxp-20230630.xsd EX-101.SCH 2935
6 XBRL LABEL FILE tnxp-20230630_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE tnxp-20230630_pre.xml EX-101.PRE 22343
11 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8ka-063023_htm.xml XML 3733
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36019 | Film No.: 231095084
SIC: 2834 Pharmaceutical Preparations